$16.74
-0.26-1.53%
At close: -
$16.75
0.010.06%
After Hours: 7:55 PM EDT
Comments
Loading...
Latest news for Teva Pharmaceutical Indus (NYSE:TEVA) Stock
Teva Pharmaceutical Indus Stock (NYSE: TEVA)
Categories: All
Friday, February 21, 2025
Tuesday, February 18, 2025
Sunday, February 16, 2025
Monday, February 10, 2025
Sunday, February 02, 2025
Thursday, January 30, 2025
Wednesday, January 29, 2025
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
- Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
- Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
- Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
- Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Teva Sees FY25 Revenue $16.8B-$17.4B Vs $17.0...
- Teva Pharmaceuticals shares are trading lower...
- Teva Pharmaceutical Indus Q4 2024 Adj EPS $0....
- Earnings Scheduled For January 29, 2025
Tuesday, January 28, 2025
Monday, January 27, 2025
Thursday, January 23, 2025
Wednesday, January 22, 2025
Friday, January 17, 2025
- Teva Challenges Drug Price Law's Impact On Innovation, Generics
- Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
- Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
- 'Ozempic Is In The Next Round Of Medicare Dru...
- Piper Sandler Maintains Overweight on Teva Ph...